FW
ABBV icon

FullCircle Wealth’s AbbVie ABBV Stock Holding History

FullCircle Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.41M Sell
6,508
-175
-3% -$35.6K 0.49% 64
2025
Q2 		$1.32M Buy
6,683
+165
+3% +$30.7K 0.49% 61
2025
Q1 		$1.25M Buy
6,518
+80
+1% +$15.6K 0.52% 56
2024
Q4 		$1.25M Buy
6,438
+36
+0.6% +$6.62K 0.51% 60
2024
Q3 		$1.21M Buy
6,402
+8
+0.1% +$1.49K 0.54% 54
2024
Q2 		$1.13M Buy
+6,394
New +$1.06M 0.55% 55

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FullCircle Wealth's ABBV Position: Q3 2025 in Review

FullCircle Wealth reduced its AbbVie (ABBV) stake by 2.6% in Q3 2025, selling an estimated $35.6K and leaving 6,508 shares worth $1.41M. The position accounts for 0.49% of the portfolio, ranked #64.

FullCircle Wealth first reported a position in ABBV in Q2 2024 and has held it in 6 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • FullCircle Wealth held 6,508 shares of AbbVie worth $1.41M as of Q3 2025.
  • FullCircle Wealth sold 175 AbbVie shares in Q3 2025, an estimated $35.6K.
  • AbbVie made up 0.49% of FullCircle Wealth's portfolio in Q3 2025, its #64 holding.
  • FullCircle Wealth first reported a position in AbbVie in Q2 2024 and has held it in 6 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on FullCircle Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.